Milsing d.o.o.   Report issue

For profit Phase 4
Founded: Zagreb Croatia (Hrvatska) (1993)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2007
NCT00446485
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

yinhsing (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebrovascular Disorders (Phase 4)

Cognitive Dysfunction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1